Clinical Trials Logo

Cat Hypersensitivity clinical trials

View clinical trials related to Cat Hypersensitivity.

Filter by:
  • None
  • Page 1

NCT ID: NCT02311413 Completed - Cat Allergy Clinical Trials

A Randomized Prospective Clinical Trial of Fel d 1 Peptide Immunotherapy

Start date: March 9, 2015
Phase: Phase 2
Study type: Interventional

The goal of this study is to identify changes in cells that are related to the treatment with Cat-PAD (ToleroMune Cat).

NCT ID: NCT02237196 Completed - Cat Allergy Clinical Trials

Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy

Start date: March 3, 2015
Phase: Phase 1/Phase 2
Study type: Interventional

This trial will test whether a novel therapeutic approach, cat immunotherapy combined with an investigational new drug called MEDI9929/AMG 157 (an anti-TSLP [thymic stromal lymphopoietin] antibody being co-developed by Amgen and MedImmune) can lead to lasting tolerance to cat allergen.The objective of the study is to determine whether one year of immunotherapy combined with MEDI9929/AMG 157 can induce tolerance to cat allergen.